DECHRA PHARMACEUTICALS LIMITED

Company number 03369634

Date	Type	Description	View / Download
26 Oct 2018	AA	Group of companies' accounts made up to 30 June 2018	(166 pages)
17 Sep 2018	SH01	Statement of capital following an allotment of shares on 12 September 2018 GBP 1,023,316.35	(3 pages)
02 Jul 2018	SH01	Statement of capital following an allotment of shares on 5 June 2018 GBP 1,023,296.35	(3 pages)
18 May 2018	CS01	Confirmation statement made on 13 May 2018 with no updates ANNOTATION Clarification a second filed CS01 (trading status of shares and exemption from keeping a register of people with significant control (psc)) was registered on 28/01/2019	(4 pages)
17 May 2018	SH01	Statement of capital following an allotment of shares on 24 April 2018 GBP 1,023,266.35	(4 pages)
14 Mar 2018	SH01	Statement of capital following an allotment of shares on 5 March 2018 GBP 1,023,036.56	(4 pages)
06 Mar 2018	RP04SH01	Second filing of a statement of capital following an allotment of shares on 14 February 2018 GBP 1,022,879.52	(7 pages)
19 Feb 2018	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES13 ‐ Share purchase agreement 12/02/2018 RES10 ‐ Resolution of allotment of securities	(3 pages)
14 Feb 2018	SH01	Statement of capital following an allotment of shares on 13 February 2018 GBP 1,022,879.52 ANNOTATION Clarification a second filed SH01 was registered on 06/03/2018.	(4 pages)
07 Feb 2018	SH01	Statement of capital following an allotment of shares on 6 February 2018 GBP 986,173.27	(3 pages)
05 Jan 2018	SH01	Statement of capital following an allotment of shares on 14 December 2017 GBP 934,861.03	(4 pages)
27 Oct 2017	AA	Group of companies' accounts made up to 30 June 2017	(177 pages)
26 Oct 2017	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES13 ‐ That pursuant to section 701 of the 701 of the 2006 act, the company is unconditionally authorised to make market purchases (within the meaning of 2006 act) of ordinary shares in the capital of the company (shares), provided that: the maximum number of shares which may be purchased is 9,318,140; (representing 100f the company's issued ordinary share capital; the minimum price is £0.01; 20/10/2017 RES10 ‐ Resolution of allotment of securities	(6 pages)
15 Sep 2017	SH01	Statement of capital following an allotment of shares on 14 September 2017 GBP 931,961.05	(3 pages)
10 Jul 2017	SH01	Statement of capital following an allotment of shares on 26 June 2017 GBP 931,787.56	(4 pages)
03 Jul 2017	AP03	Appointment of Ms Melanie Jane Hall as a secretary on 1 July 2017	(2 pages)
03 Jul 2017	TM02	Termination of appointment of Suzana Cross as a secretary on 1 July 2017	(1 page)
24 May 2017	CS01	Confirmation statement made on 13 May 2017 with no updates	(3 pages)
23 May 2017	SH01	Statement of capital following an allotment of shares on 8 May 2017 GBP 931,677.86	(4 pages)
15 Mar 2017	SH01	Statement of capital following an allotment of shares on 14 March 2017 GBP 930,963.96	(4 pages)
12 Jan 2017	SH01	Statement of capital following an allotment of shares on 14 December 2016 GBP 930,521.9	(4 pages)
04 Jan 2017	TM01	Termination of appointment of Michael Redmond as a director on 21 October 2016	(1 page)
03 Jan 2017	AP01	Appointment of Mr Richard John Cotton as a director on 3 January 2017	(2 pages)
13 Dec 2016	AP01	Appointment of Dr Lawson Macartney as a director on 1 December 2016	(3 pages)
22 Nov 2016	AA	Group of companies' accounts made up to 30 June 2016	(166 pages)